Table 1.
The correlation between FPR2 expression and clinical pathologic parameters in GC.
| Clinicopathological parameter | Total No. | FPR2 | p value | |
|---|---|---|---|---|
| Negative (%) | Positive (%) | |||
| Age, y | ||||
| ≤60 | 108 | 34(31.5) | 74(68.5) | 0.156 |
| >60 | 61 | 13(21.3) | 48(78.7) | |
| Sex | ||||
| Female | 51 | 22(43.2) | 29(56.8) | 0.003 |
| Male | 118 | 25(21.2) | 93(78.8) | |
| Histological grade | ||||
| G1 + G2 | 49 | 13(26.5) | 36(73.5) | 0.812 |
| G3 | 120 | 34(28.3) | 86(71.7) | |
| TNM stage | ||||
| I | 28 | 16(57.1) | 12(42.9) | 0.002 |
| II | 40 | 8(20) | 32(80) | |
| III | 67 | 17(25.4) | 50(74.6) | |
| IV | 34 | 6(17.6) | 28(82.4) | |
| Serosal invasion | ||||
| Absent | 52 | 21(40.4) | 31(59.6) | 0.015 |
| Present | 117 | 26(22.2) | 91(77.8) | |
| Lymph node metastasis | ||||
| Absent | 68 | 26(38.2) | 42(61.8) | 0.043 |
| Present | 101 | 24(23.8) | 77(76.2) | |